Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Transitional Cell × Dexamethasone × 1 year × Clear all

Sponsor

Conditions

Multiple Myeloma 221 Precursor Cell Lymphoblastic Leukemia-Lymphoma 46 Recurrence 31 Neoplasms 20 Burkitt Lymphoma 20 Neoplasms, Plasma Cell 16 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 12 Immunoglobulin Light-chain Amyloidosis 11 Neoplasm Metastasis 10 Leukemia 10 Lung Neoplasms 9 Carcinoma, Non-Small-Cell Lung 8 Breast Neoplasms 8 Prostatic Neoplasms 7 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 7 Leukemia, Myeloid, Acute 7 Lymphoma 6 Leukemia, Biphenotypic, Acute 6 Lymphoma, Non-Hodgkin 5 Triple Negative Breast Neoplasms 4 Smoldering Multiple Myeloma 4 Neoplasm, Residual 4 Lymphoma, Mantle-Cell 4 Hodgkin Disease 4 Colorectal Neoplasms 4 Brain Neoplasms 4 Waldenstrom Macroglobulinemia 3 Vomiting 3 Rectal Neoplasms 3 Plasmacytoma 3

Interventions

pembrolizumab 38 Gemcitabine 20 enfortumab vedotin 19 Cisplatin 17 Nivolumab 16 atezolizumab 14 Magnetic Resonance Spectroscopy 14 avelumab 13 Carboplatin 12 Specimen Handling 10 Docetaxel 10 sacituzumab govitecan 9 Paclitaxel 7 Ipilimumab 7 Fluorodeoxyglucose F18 5 pemigatinib 4 toripalimab 3 erdafitinib 3 durvalumab 3 cabozantinib 3 X-Rays 3 Taxes 3 Mitomycin 3 Immunoglobulin G 3 CTLA-4 Antigen 3 Biopsy 3 tislelizumab 2 lenvatinib 2 eribulin 2 dodecyl maltoside 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡